Hong Shen

7PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markersTumour immunologyInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 26, 2026
Angiogenic Prognostic Signature for Stratification in Hepatocellular Carcinoma.

|Dec 05, 2021
Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality.

Changjing Cai, Xiangyang Zhang, Yihan Liu

|Oct 08, 2021
Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes.

Wantao Wu, Yihan Liu, Shan Zeng

|Mar 03, 2021
In respond to commensal bacteria: γδT cells play a pleiotropic role in tumor immunity.

Yongting Liu, Ying Han, Shan Zeng

|Feb 29, 2020
FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer.

Yihong Chen, Ganlu Deng, Yaojie Fu

|Jan 25, 2019
Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1.

Ling Yin, Yihong Chen, You Zhou

Pageof 2

Frequent Collaborators